AmSurg stock has an average 12-month price target of $67.45. The company’s stock has a 50-day moving average of $65 and a 200-day moving average of $58, according to the report.
More articles on transactions and valuation issues:
4 recent orthopedics-driven ASC plans & openings
Ellis Hospital is crowdfunding its new surgery center: 4 insights
Nobilis Healthcare receives $25M loan from GE Capital
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
